FINWIRES · TerminalLIVE
FINWIRES

研究快訊:紐蒙特礦業第一季業績強勁超預期,受金價創紀錄上漲推動

By

-- 獨立研究機構CFRA向提供了以下研究報告。 CFRA分析師總結如下:紐蒙特礦業公司公佈的第一季調整後每股收益為2.90美元,超出市場預期0.73美元(33%),高於2025年第一季的1.25美元,主要得益於黃金實際價格飆升66%至每盎司4,900美元。營收成長46%至73億美元(超出市場預期11%),調整後EBITDA幾乎翻倍至52億美元,儘管由於礦山開採順序調整,歸屬於母公司黃金的產量下降了15%至130萬盎司。我們認為,這些業績表明,在金價高企的環境下,紐蒙特礦業的商業模式具有顯著的營運槓桿效應,而價格上漲抵消了產量下降的影響。儘管第一季產量有所下降,但管理層重申了2026年530萬盎司的產量預期,其中52%的產量將集中在下半年。該公司已完成60億美元的股票回購授權,並宣布了一項額外的60億美元回購計劃,第一季末現金餘額為88億美元,淨現金部位為32億美元。我們認為,穩健的資產負債表、嚴謹的資本配置以及2026年後恢復生產成長的計劃,共同支撐了公司的長期價值主張。

Related Articles

Asia

Dongjiang Environmental's Loss Widens 2.7% in Q1

Dongjiang Environmental (HKG:0895, SHE:002672) recorded an attributable loss of 150.2 million yuan in the first quarter of 2026, 2.7% wider than 146.3 million yuan a year prior, according to a Monday Hong Kong bourse filing.Loss per share widened to 0.14 yuan from 0.13 yuan in the corresponding period of the previous fiscal year.The waste disposal management company's revenue from operations declined 13% to 602.6 million yuan from 695.9 million yuan in the year-ago period.

$HKG:0895$SHE:002672
Sectors

Sector Update: Health Care Stocks Edge Higher Pre-Bell Monday

Health care stocks were edging higher pre-bell Monday, with the State Street Health Care Select Sector SPDR ETF (XLV) up 0.2% and the iShares Biotechnology ETF (IBB) marginally advancing.Organon (OGN) has agreed to be acquired by Sun Pharmaceutical Industries for $14 per share in an all-cash deal with an $11.75 billion enterprise valuation, the companies said. Shares of Organon were up more than 17% premarket.Oruka Therapeutics (ORKA) stock was up more than 34% after the company said 63.5% of patients treated with ORKA-001 achieved the primary endpoint of complete skin clearance at week 16 in a phase 2a trial in moderate-to-severe plaque psoriasis.Ligand Pharmaceuticals (LGND) shares were up more than 3% after the company said it has agreed to purchase biotechnology peer Xoma Royalty (XOMA) in an all-cash deal valued at roughly $739 million.

$IBB$LGND$OGN$ORKA$XLV$XOMA
Asia

Zuoli Kechuang Logs Drop in Q1 Profit

Zuoli Kechuang Micro-finance Company (HKG:6866) recorded a decline in attributable profit in the first quarter of 2026 to 13.6 million yuan from 14.8 million yuan a year prior, according to a Monday Hong Kong bourse filing.Net interest income for the three months slipped to 28.4 million yuan from 35.2 million yuan in the year-ago period.

$HKG:6866